| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner, See Remarks
2 companies
Aghazadeh Behzad is a Director, 10% Owner, See Remarks at WHWK with holdings across 2 companies. Recent SEC Form 4 filings include 3 buys and 0 sells.
Estimated insider holdings value: $87.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | SCTX Scribe Therapeutics Inc. | Director, 10% Owner, See Remarks | Buy | 2,391,238 | $15.16 | $36,259,761.25 | +35.1% |